Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Typical lung carcinoids(TCs)are rare tumors with good,although heterogeneous,prognosis.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Briganti V
Authors: Briganti V, Berti V, Abenavoli E, Linguanti F, Ciaccio A,
Keywords: typical lung carcinoid, FDG PET, SSTR imaging, MTV, TLG,
#2983 Differential TGF-β Signalling in Typical and Atypical Bronchial Carcinoids
Introduction: Typical and atypical bronchial carcinoids (TBC and ABC) are well-differentiated neuroendocrine neoplasms (NEN). Metastatic BC having low to moderate mitotic count may still be treated with somatostatin analogues and mTOR inhibitors; however, TBC and ABC have been reported to respond very differently to therapy and an effective treatment algorithm is still lacking. TGF-β is known for its ability to activate mTOR pathway and induce epithelial mesenchymal transition, affecting cell pathophysiological capabilities such as proliferation, migration and tissue invasiveness.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Borges de Souza P
Authors: Borges de Souza P, Tagliatti V, Capobianco S, Ambrosio M, Chinnici S,
Keywords: Neuroendocrine neoplasms, bronchial carcinoids, TGF-β,
Introduction: An association between preoperative Vasostatin-1 (VS-1) plasma level and pathological features of aggressiveness was previously reported in patients with surgically resected nonfunctioning (NF) PanNET.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Andreasi V
Authors: Andreasi V, Partelli S, Manzoni M, Muffatti F, Colombo B,
Keywords: pancreatic neuroendocrine tumors, biomarkers, chromogranin A, vasostatin 1, recurrence,
Introduction: Carcinoids of the lung are a wide range of tumors with various malignancy.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Gurevich L, Voronkova I, Ashevskay V, Bondarenco E, Fedorov D,
Keywords: lung, carcinoid, immunophenotype,
Introduction: The risk of recurrence after radical surgery performed for pancreatic neuroendocrine tumors (PanNET) is reported between 10 and 30%. Nowadays, no adjuvant therapy is recommended for these patients and specific treatments are offered only when recurrence occurs. Nevertheless, among the available systemic and locoregional treatments, there are no specific recommendations on which the best option could be for treating recurrent disease.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Andreasi V
Authors: Andreasi V, Partelli S, Landoni L, Nessi C, Muffatti F,
Keywords: pancreatic neuroendocrine tumors, recurrence, surgery, locoregional treatment, systemic treatment,